Uniprogen Biotech Private Limited - Company Profile

It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 2010.
2010 Navi Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Uniprogen Biotech Private Limited

Uniprogen Biotech Private Limited, a active private limited company, was established on 02 January 2010 in Navi Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2010PTC198320. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.05 Cr and a paid-up capital of ₹1.01 Cr.

It upholds a compliant status. Employing 3 professional, Its leadership includes Santanu Nayak (Director), Anandkumar Bhanupratap Singh (Director), Priyajit Chakraborty (Additional Director). Past directors included Bablu Ramchandra Gupta, Shailendra Paltan Jaiswal, Soundarrajan Santhanaraman. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Shop No 16, Ashapura Chs Plot No 51, Sec 19, Airoli, Navi Mumbai, Maharashtra, 400708.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909MH2010PTC198320

  • Registration Number

    198320

  • Incorporation Date

    02 January 2010

  • Authorized Capital

    ₹1.05 Cr

  • Paid-Up Capital

    ₹1.01 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.05 Cr
  • Paid Up Capital ₹ 1.01 Cr
  • Company Age 16 Year, 1 Month
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth **** -30.19%
  • Profit Growth **** 78.85%
  • Ebitda **** 63.62%
  • Net Worth -8.83%
  • Total Assets **** 43.37%
Company report

Uniprogen Biotech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Uniprogen Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Uniprogen Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Santanu Nayak Director 15 Jan 2010 Current
Anandkumar Bhanupratap Singh Director 15 Jan 2010 Current
Priyajit Chakraborty Additional Director 19 Mar 2020 Current
Boomi Nathan Shankar Director 02 Jan 2010 Current
Madhu Mehta Director 01 Apr 2013 Current
Nilesh Rampratap Chaubey Director 03 Aug 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Apr 2019 Past
Pramod Abcsdd Director 29 Jul 2015 Past
Pramod Abcsdd Director 25 Apr 2019 Past
Pramod Abcsdd Additional Director 30 Sep 2014 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Uniprogen Biotech.

Uniprogen Biotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 30.19% decrease. The company also saw a substantial improvement in profitability, with a 78.85% increase in profit. The company's net worth dipped by a decrease of 8.83%.

Uniprogen Biotech revenue growth over time
Uniprogen Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -30.19%
*******
*******
*******
*******
Revenue from Operations
*******
 -34.39%
*******
*******
*******
*******
Total Assets
*******
 43.37%
*******
*******
*******
*******
Profit or Loss
*******
 78.85%
*******
*******
*******
*******
Net Worth
*******
 -8.83%
*******
*******
*******
*******
EBITDA
*******
 63.62%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Uniprogen Biotech?

In 2021, Uniprogen Biotech had a promoter holding of 98.50% and a public holding of 1.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Uniprogen Biotech?

Uniprogen Biotech has a workforce of 3 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Uniprogen Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uniprogen Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Uniprogen Biotech
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Uniprogen Biotech Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.

  • Balance Sheet

    Uniprogen Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Priyajit Chakraborty was appointed as a Additional Director was appointed as a Additional Director on 19 Mar 2020 & has been associated with this company since 5 years 10 months . was recorded as a recent event.

  • Director Appointment

    The activity Nilesh Rampratap Chaubey was appointed as a Director was appointed as a Director on 03 Aug 2018 & has been associated with this company since 7 years 6 months . was completed.

  • Director Appointment

    Progress on Madhu Mehta was appointed as a Director was appointed as a Director on 01 Apr 2013 & has been associated with this company since 12 years 10 months . was documented.

  • Director Appointment

    Santanu Nayak was appointed as a Director was appointed as a Director on 15 Jan 2010 & has been associated with this company since 16 years 29 days . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Uniprogen Biotech Private Limited?

The CIN of Uniprogen Biotech Private Limited is U51909MH2010PTC198320.

Where is Uniprogen Biotech Private Limited headquartered?

Uniprogen Biotech Private Limited is headquartered at Shop No 16, Ashapura Chs Plot No 51, Sec 19, Airoli, Navi Mumbai, Maharashtra, 400708.

When was Uniprogen Biotech Private Limited incorporated?

Uniprogen Biotech Private Limited was incorporated on 02 January 2010.

Who are the current directors of Uniprogen Biotech Private Limited?

The current directors of Uniprogen Biotech Private Limited are

What is the primary industry of Uniprogen Biotech Private Limited?

The primary industry of Uniprogen Biotech Private Limited is Trade.

Is Uniprogen Biotech Private Limited a listed company?

Uniprogen Biotech Private Limited is unlisted.

What is the capital structure of Uniprogen Biotech Private Limited?

The authorized capital of Uniprogen Biotech Private Limited is ₹1.05 Cr, and the paid-up capital is ₹1.01 Cr.

What is the compliance status of Uniprogen Biotech Private Limited?

The compliance status of Uniprogen Biotech Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available